Assessment of Glucose Lowering Medications’ Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes

The results from many cardiovascular (CV) outcome trials suggest that glucose lowering medications (GLMs) are effective for the CV clinical risk management of type 2 diabetes (T2D) patients. The aim of this study is to compare the effectiveness of two GLMs (SGLT2i and GLP-1RA) for the CV clinical ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciannameo, Veronica, Fadini, Gian Paolo, Bottigliengo, Daniele, Avogaro, Angelo, Baldi, Ileana, Gregori, Dario, Berchialla, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690556/
https://www.ncbi.nlm.nih.gov/pubmed/36429543
http://dx.doi.org/10.3390/ijerph192214825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690556/
https://www.ncbi.nlm.nih.gov/pubmed/36429543
http://dx.doi.org/10.3390/ijerph192214825

Ejemplares similares